This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health, to Emory University, a private research institution in Atlanta, Georgia. The contract, valued at $6,963,671.38, is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases. The contract has no set-aside designation. Emory University,...
This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia. The contract, valued at $10,564,646.55, is a delivery order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract supports Emory's research and services related to the VTEU program, which focuses on the...
This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Emory University, a private university and research institution located in Atlanta, Georgia. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which focuses on the development and evaluation of vaccines and treatments for infectious diseases. The contract has a total potential value of $263,956.53 and a period of performance ending on...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded Emory University a delivery order contract for Vaccine Treatment and Evaluation Units (VTEU) services. The contract has a potential value of $4,337,100.57 and runs from July 2017 through October 2019. This delivery order is part of the larger VTEU contract vehicle, which allows the government to procure clinical trial and data collection services...
This is a Delivery Order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports the development and evaluation of vaccines and treatments for infectious diseases. The Delivery Order, with a ceiling value of $4,606,034.89, covers overall...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a delivery order contract to Emory University Office of Sponsored Programs Division on April 19, 2017 for "Vaccine Treatment and Evaluation Units" services. The contract has a potential value of $543,459.23 and a completion date of December 31, 2021. This delivery order is part of the larger Vaccine and Treatment Evaluation Units (VTEU) indefinite...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases, to Emory University for $76,153 to support the Vaccine and Treatment Evaluation Units (VTEU) program. The order was issued under the VTEU indefinite delivery contract and has a period of performance through May 31, 2021. Emory University is a private research university with an extensive track record of federally funded research...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Emory University, a private research institution in Atlanta, Georgia. The contract is part of NIAID's Vaccine and Treatment Evaluation Units (VTEU) program, which supports the evaluation of vaccines and treatments for infectious diseases. The contract has a ceiling value of $3,128,475.78 and a period of performance through December...
This is a delivery order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Emory University in the amount of $1,209,390.27. The purpose is to transfer active work from a previous contract (HHSN272200800005C) to the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Indefinite Quantity (IDIQ) contract (HHSN27220130018I). This delivery order does not have a set-aside...
This is a federal contract award to Emory University, a private research institution in Atlanta, Georgia, by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). The contract, with a ceiling value of $5,025,057.70, is for the development, implementation, and research of laboratory assays for a Phase I clinical trial to examine the safety, immunogenicity, and 'omics response to MVA-multi filo and AD26 Zaire vaccines in healthy...
This federal contract award is for the Vaccine Treatment and Evaluation Units (VTEU) program, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $1,670,222.75, was awarded to Emory University, a private research institution in Atlanta, Georgia, to provide services related to the development and evaluation of vaccines and treatments for infectious diseases. The contract is a delivery order under a larger VTEU Indefinite Delivery Contract (IDC). The award does not have a set-aside designation, and the contract performance period extends through May 31, 2024. As a leading academic and research center, Emory University has an extensive track record of conducting federally funded research in the areas of biomedical science, public health, and clinical studies, making them a valuable partner for the NIAID's efforts to advance medical countermeasures against infectious diseases.